Hairy cell leukemia: Past, present and future Journal Article


Authors: Getta, B. M.; Park, J. H.; Tallman, M. S.
Article Title: Hairy cell leukemia: Past, present and future
Abstract: This brief review highlights the sequence of therapeutic milestones and advances in our understanding of the biology of hairy cell leukemia (HCL) with a focus on recent molecular findings and how these may be applied to improve disease outcomes in the future. Targeted therapy is discussed in the context of the recently identified BRAF mutation and other genetic findings. © 2015 Published by Elsevier Ltd.
Keywords: gene mutation; rituximab; gene expression; hematopoietic stem cell; b raf kinase; braf; pentostatin; cladribine; hairy cell leukemia; b lymphocyte receptor; vemurafenib; dabrafenib; trametinib; moxetumomab pasudotox; ibrutinib; human; priority journal; article
Journal Title: Best Practice and Research: Clinical Haematology
Volume: 28
Issue: 4
ISSN: 1521-6926
Publisher: Elsevier Inc.  
Date Published: 2015-12-01
Start Page: 269
End Page: 272
Language: English
DOI: 10.1016/j.beha.2015.10.015
PROVIDER: scopus
PUBMED: 26614906
PMCID: PMC5008915
DOI/URL:
Notes: Article -- Export Date: 3 February 2016 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Martin Stuart Tallman
    649 Tallman
  2. Jae Hong Park
    356 Park
  3. Bartlomiej Marcin Getta
    29 Getta